VAXART, INC. financials

VXRT CIK 0000072444

Source: EDGAR filings · Built 2026-06-19T03:21:13Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 7.57M -45.32M -72.32M -104.38M -64.99M -24.97M
EBITDA 26.65M -57.44M -74.72M -108.78M -68.54M -27.46M
Working Capital 49.37M -22.62M 31.81M 81.53M 158.38M 116.77M
Net Debt -54.81M -34.17M -14.67M -22.31M -130.74M -59.66M
Operating Margin 7.62% -230.99% -1129.52% -107090.65% -8156.05% -745.67%
Net Margin 6.88% -233.27% -1117.56% -100708.41% -7900.22% -796.34%
Return on Equity (ROE) 18.60% -113.62% -142.66% -97.43% -37.58% -26.11%
Return on Assets (ROA) 8.77% -40.24% -89.80% -70.04% -31.86% -21.12%
Current Ratio 1.57× 0.75× 3.32× 5.55× 15.69× 10.93×
Debt-to-Equity 0.10× 0.30× 0.35× 0.20× 0.07× 0.06×
Effective Tax Rate 2.83% -0.39% -0.32% -0.06% -0.15% -0.74%
Cash Conversion Ratio 0.47× 0.67× 0.85× 0.88× 0.85× 0.74×
Accruals Ratio 0.05× -0.13× -0.13× -0.08× -0.05× -0.06×
SBC % of Revenue 3.50% 40.07% 191.52% 12698.13% 994.06% 107.71%
CapEx Coverage 53.20× -80.80× -37.66× -9.87× -11.60× -19.42×
Free Cash Flow Per Share $0.03 $-0.22 $-0.50 $-0.81 $-0.54 $-0.28

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 237.26M 28.70M 7.38M
Research and Development Expense 201.58M 74.21M 68.14M 81.05M 48.75M 19.86M
Operating Expenses 219.18M 94.99M 90.73M 114.69M 73.64M 34.22M
Operating Income (Loss) 18.07M -66.29M -83.35M -114.59M -72.75M -30.17M
Income Tax Expense (Benefit) 476.00K 260.00K 261.00K 67.00K 107.00K 238.00K
Net Income (Loss) Attributable to Parent 16.33M -66.95M -82.47M -107.76M -70.47M -32.22M
Earnings Per Share, Basic $0.07 $-0.33 $-0.57 $-0.84 $-0.58
Weighted Average Number of Shares Outstanding, Basic 230.27M 202.14M 144.82M 127.68M 121.45M
Earnings Per Share, Diluted $0.07 $-0.33
Weighted Average Number of Shares Outstanding, Diluted 230.35M 202.14M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 34.76M 44.01M 143.75M
Assets, Current 136.12M 68.26M 45.54M 99.45M 169.17M 128.53M
Assets 186.08M 166.39M 91.83M 153.85M 221.17M 152.58M
Liabilities, Current 86.75M 90.88M 13.72M 17.92M 10.78M 11.76M
Liabilities 98.28M 107.46M 34.02M 43.25M 33.64M 29.18M
Stockholders' Equity Attributable to Parent 87.80M 58.92M 57.80M 110.60M 187.53M 123.40M
Common Stock, Shares, Outstanding 240.49B 227.77B 153.45B 134.20B 125.59B 110.27B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 7.71M -44.76M -70.45M -94.78M -59.83M -23.75M
Payments to Acquire Property, Plant, and Equipment 145.00K 554.00K 1.87M 9.60M 5.16M 1.22M
Net Cash Provided by (Used in) Investing Activities 16.63M -21.32M 43.95M -20.41M -49.10M -1.22M
Net Cash Provided by (Used in) Financing Activities 4.24M 56.56M 15.24M 17.46M 125.80M 138.31M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (VXRT CIK 0000072444), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CRBP

Corbus Pharmaceuticals Holdings, Inc.

MCLE

Medicale Corp.

TPET

TRIO PETROLEUM CORP